TANZIC Trademark

Trademark Overview

On Wednesday, March 26, 2008, a trademark application was filed for TANZIC with the United States Patent and Trademark Office. The USPTO has given the TANZIC trademark a serial number of 77432320. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 9, 2012. This trademark is owned by Glaxo Group Limited. The TANZIC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
tanzic

General Information

Serial Number77432320
Word MarkTANZIC
Filing DateWednesday, March 26, 2008
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 9, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 16, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 31, 2008
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, January 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 9, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 14, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 13, 2011EXTENSION 5 GRANTED
Wednesday, June 8, 2011EXTENSION 5 FILED
Wednesday, June 8, 2011TEAS EXTENSION RECEIVED
Friday, October 22, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 21, 2010EXTENSION 4 GRANTED
Wednesday, October 20, 2010EXTENSION 4 FILED
Wednesday, October 20, 2010TEAS EXTENSION RECEIVED
Friday, May 21, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 20, 2010EXTENSION 3 GRANTED
Wednesday, May 19, 2010EXTENSION 3 FILED
Wednesday, May 19, 2010TEAS EXTENSION RECEIVED
Friday, May 14, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 3, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 21, 2010EXTENSION 2 GRANTED
Thursday, December 3, 2009EXTENSION 2 FILED
Wednesday, January 20, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 3, 2009TEAS EXTENSION RECEIVED
Monday, October 26, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 12, 2009EXTENSION 1 GRANTED
Tuesday, May 12, 2009EXTENSION 1 FILED
Tuesday, May 12, 2009TEAS EXTENSION RECEIVED
Monday, May 11, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 11, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 9, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 16, 2008PUBLISHED FOR OPPOSITION
Wednesday, August 27, 2008NOTICE OF PUBLICATION
Thursday, August 14, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 14, 2008ASSIGNED TO LIE
Friday, August 8, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 5, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 5, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 5, 2008TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 30, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, June 30, 2008LETTER OF SUSPENSION E-MAILED
Monday, June 30, 2008SUSPENSION LETTER WRITTEN
Sunday, June 29, 2008ASSIGNED TO EXAMINER
Monday, March 31, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

tanzic pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic